This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Most glomerular diseases are immunologically mediated disorders of the kidney and are common causes of ESKD. In addition to supportive therapy, a wide range of immunosuppressive agents are used in the management of patients with these conditions. Immunosuppression requires a careful balance of risk and benefits, and many of these agents have a narrow therapeutic window and require close monitoring. This review describes the side effects of immunosuppressive agents used in recent randomized, controlled trials of glomerular disease, and highlights some of the key adverse events that determine the choice and prescription of these medications.
- glomerular disease
- rituximab
- glucocorticoids
- mycophenolate mofetil
- cyclophosphamide
- tacrolimus
- adverse events
- lupus nephritis
- ANCA
- membranous nephropathy
- IgA nephropathy
- Immunosuppressive Agents
- glomerulonephritis
- immunosuppression
- Kidney Failure, Chronic
- kidney
- Copyright © 2018 by the American Society of Nephrology
In this issue
